{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:51:29Z","timestamp":1790905889229,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1124\/mol.119.117531","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T23:55:12Z","timestamp":1565222112000},"page":"485-492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Structural Basis for Diltiazem Block of a Voltage-Gated Ca2+ Channel"],"prefix":"10.1016","volume":"96","author":[{"given":"Lin","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer M.","family":"Gamal El-Din","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Lenaeus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Catterall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.119.117531_bib1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1146\/annurev.cellbio.16.1.521","article-title":"Structure and regulation of voltage-gated Ca2+ channels","volume":"16","author":"Catterall","year":"2000","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1124\/mol.119.117531_bib2","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a003947","article-title":"Voltage-gated calcium channels","volume":"3","author":"Catterall","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1124\/mol.119.117531_bib3","doi-asserted-by":"crossref","first-page":"11331","DOI":"10.1073\/pnas.1309452110","article-title":"Catalysis of Na+ permeation in the bacterial sodium channel NaVAb","volume":"110","author":"Chakrabarti","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.119.117531_bib4","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1124\/mol.64.2.491","article-title":"Molecular determinants of Ca2+ potentiation of diltiazem block and Ca2+-dependent inactivation in the pore region of Cav1.2","volume":"64","author":"Dilmac","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.119.117531_bib5","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1085\/jgp.201711884","article-title":"Molecular dissection of multiphase inactivation of the bacterial sodium channel NaVAb","volume":"151","author":"Gamal El-Din","year":"2019","journal-title":"J Gen Physiol"},{"key":"10.1124\/mol.119.117531_bib6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fphar.2017.00286","article-title":"Discovery and development of calcium channel blockers","volume":"8","author":"Godfraind","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1124\/mol.119.117531_bib7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0014-5793(84)81199-0","article-title":"(\u2212)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle","volume":"176","author":"Goll","year":"1984","journal-title":"FEBS Lett"},{"key":"10.1124\/mol.119.117531_bib8","doi-asserted-by":"crossref","first-page":"24471","DOI":"10.1074\/jbc.271.40.24471","article-title":"Transfer of high sensitivity for benzothiazepines from L-type to class A (BI) calcium channels","volume":"271","author":"Hering","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.119.117531_bib9","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1085\/jgp.69.4.497","article-title":"Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction","volume":"69","author":"Hille","year":"1977","journal-title":"J Gen Physiol"},{"key":"10.1124\/mol.119.117531_bib10","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0026-895X(24)12696-X","article-title":"Molecular determinants of diltiazem block in domains IIIS6 and IVS6 of L-type Ca2+ channels","volume":"58","author":"Hockerman","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.119.117531_bib11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.pharmtox.37.1.361","article-title":"Molecular determinants of drug binding and action on L-type calcium channels","volume":"37","author":"Hockerman","year":"1997","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/mol.119.117531_bib12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev.pa.24.040184.002131","article-title":"Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs","volume":"24","author":"Hondeghem","year":"1984","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/mol.119.117531_bib13","doi-asserted-by":"crossref","first-page":"20113","DOI":"10.1074\/jbc.271.33.20113","article-title":"Identification of benz(othi)azepine-binding regions within L-type calcium channel \u03b11 subunits","volume":"271","author":"Kraus","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.119.117531_bib14","doi-asserted-by":"crossref","first-page":"27205","DOI":"10.1074\/jbc.273.42.27205","article-title":"Molecular mechanism of diltiazem interaction with L-type Ca2+ channels","volume":"273","author":"Kraus","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.119.117531_bib15","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/302790a0","article-title":"Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells","volume":"302","author":"Lee","year":"1983","journal-title":"Nature"},{"key":"10.1124\/mol.119.117531_bib16","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1073\/pnas.80.3.860","article-title":"A unitary mechanism of calcium antagonist drug action","volume":"80","author":"Murphy","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.119.117531_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau2486","article-title":"Structure of the human voltage-gated sodium channel Nav1.4 in complex with \u03b21","volume":"362","author":"Pan","year":"2018","journal-title":"Science"},{"key":"10.1124\/mol.119.117531_bib18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nature11077","article-title":"Crystal structure of a voltage-gated sodium channel in two potentially inactivated states","volume":"486","author":"Payandeh","year":"2012","journal-title":"Nature"},{"key":"10.1124\/mol.119.117531_bib19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature10238","article-title":"The crystal structure of a voltage-gated sodium channel","volume":"475","author":"Payandeh","year":"2011","journal-title":"Nature"},{"key":"10.1124\/mol.119.117531_bib20","doi-asserted-by":"crossref","first-page":"18580","DOI":"10.1016\/S0021-9258(17)46667-1","article-title":"Ligand-induced accelerated dissociation of (+)-cis-diltiazem from L-type Ca2+ channels is simply explained by competition for individual attachment points","volume":"268","author":"Prinz","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.119.117531_bib21","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1126\/science.1065635","article-title":"A prokaryotic voltage-gated sodium channel","volume":"294","author":"Ren","year":"2001","journal-title":"Science"},{"key":"10.1124\/mol.119.117531_bib22","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0014-5793(86)80327-1","article-title":"Purified calcium channels have three allosterically coupled drug receptors","volume":"197","author":"Striessnig","year":"1986","journal-title":"FEBS Lett"},{"key":"10.1124\/mol.119.117531_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0733-8651(03)00111-5","article-title":"Pharmacological rate control of atrial fibrillation","volume":"22","author":"Tamariz","year":"2004","journal-title":"Cardiol Clin"},{"key":"10.1124\/mol.119.117531_bib24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature12775","article-title":"Structural basis for Ca2+ selectivity of a voltage-gated calcium channel","volume":"505","author":"Tang","year":"2014","journal-title":"Nature"},{"key":"10.1124\/mol.119.117531_bib25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature19102","article-title":"Structural basis for inhibition of a voltage-gated Ca2+ channel by Ca2+ antagonist drugs","volume":"537","author":"Tang","year":"2016","journal-title":"Nature"},{"key":"10.1124\/mol.119.117531_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2007.01.016","article-title":"Calcium channel antagonists: clinical uses\u2014past, present and future","volume":"74","author":"Triggle","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.119.117531_bib27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature19321","article-title":"Structure of the voltage-gated calcium channel Cav1.1 at 3.6 \u00c5 resolution","volume":"537","author":"Wu","year":"2016","journal-title":"Nature"},{"key":"10.1124\/mol.119.117531_bib28","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/pr.114.009654","article-title":"The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential","volume":"67","author":"Zamponi","year":"2015","journal-title":"Pharmacol Rev"},{"key":"10.1124\/mol.119.117531_bib29","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.cell.2019.04.043","article-title":"Molecular basis for ligand modulation of a mammalian voltage-gated Ca2+ channel","volume":"177","author":"Zhao","year":"2019","journal-title":"Cell"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24009726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24009726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.119.117531","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:31:44Z","timestamp":1739961104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24009726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0026895X24009726"],"URL":"https:\/\/doi.org\/10.1124\/mol.119.117531","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural Basis for Diltiazem Block of a Voltage-Gated Ca2+ Channel","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.119.117531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}